{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T12:30:23Z","timestamp":1693139423894},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,5,14]],"date-time":"2009-05-14T00:00:00Z","timestamp":1242259200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s00105-009-1767-4","type":"journal-article","created":{"date-parts":[[2009,5,12]],"date-time":"2009-05-12T18:46:29Z","timestamp":1242153989000},"page":"246-249","source":"Crossref","is-referenced-by-count":4,"title":["Erfolgreiche Therapie eines diskoiden Lupus erythematodes mit Efalizumab","Successful therapy of discoid lupus erythematosus with efalizumab"],"prefix":"10.1007","volume":"61","author":[{"given":"N.","family":"Booken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Schumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fuchslocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Goerdt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Goebeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,14]]},"reference":[{"key":"1767_CR1","doi-asserted-by":"crossref","unstructured":"Callen JP (2005) Management of cutaneous lupus erythematosus. In: Kuhn A, Lehmann P, Ruzicka T (eds) Cutaneous lupus erythematosus. Springer, Berlin Heidelberg New York Tokyo, pp 437\u2013444","DOI":"10.1007\/3-540-26581-3_31"},{"key":"1767_CR2","doi-asserted-by":"crossref","unstructured":"Sticherling M (2005) Chronic cutaneous lupus erythematosus. In: Hertl M (ed) Autoimmune diseases of the skin. Springer, Wien New York, pp 183\u2013202","DOI":"10.1007\/3-211-27377-8_9"},{"key":"1767_CR3","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1046\/j.1610-0387.2003.03024.x","volume":"1","author":"Wenzel","year":"2003","unstructured":"Wenzel J, Bieber T, Uerlich M, T\u00fcting T (2003) Systemic treatment of cutaneous lupus erythematosus. J Dtsch Dermatol Ges 1:694\u2013704","journal-title":"J Dtsch Dermatol Ges"},{"key":"1767_CR4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1529-8019.2007.00139.x","volume":"20","author":"Chacko","year":"2007","unstructured":"Chacko M, Weinberg JM (2007) Efalizumab. Dermatol Ther 20:265\u2013269","journal-title":"Dermatol Ther"},{"key":"1767_CR5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0001-7310(08)74612-X","volume":"99","author":"Guhl","year":"2008","unstructured":"Guhl G, D\u00edaz-Ley B, Fern\u00e1ndez-Herrera J (2008) Off-label use of biologic agents in the treatment of dermatosis, part 2: Etanercept, efalizumab, alefacept, rituximab, daclizumab, basiliximab, omalizumab, and cetuximab. Actas Dermosifiliogr 99:5\u201333","journal-title":"Actas Dermosifiliogr"},{"key":"1767_CR6","first-page":"337","volume":"6","author":"G\u00f3mez","year":"2007","unstructured":"G\u00f3mez M, Ruelas ME, Welsh O et al (2007) Clinical improvement of pityriasis rubra pilaris with efalizumab in a pediatric patient. J Drugs Dermatol 6:337\u2013339","journal-title":"J Drugs Dermatol"},{"key":"1767_CR7","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jaad.2005.08.025","volume":"54","author":"Clayton","year":"2006","unstructured":"Clayton TH, Ogden S, Goodfield MD (2006) Treatment of refractory subacute cutaneous lupus erythematosus with efalizumab. J Am Acad Dermatol 54:892\u2013895","journal-title":"J Am Acad Dermatol"},{"key":"1767_CR8","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/archderm.143.7.873","volume":"143","author":"Usmani","year":"2007","unstructured":"Usmani N, Goodfield M (2007) Efalizumab in the treatment of discoid lupus erythematosus. Arch Dermatol 143:873\u2013877","journal-title":"Arch Dermatol"},{"key":"1767_CR9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2230.2007.02648.x","volume":"33","author":"Hamprecht","year":"2008","unstructured":"Hamprecht A, T\u00fcting T, Bieber T, Wenzel J (2008) Successful treatment of recalcitrant malar rash in a patient with cutaneous lupus erythematosus with efalizumab. Clin Exp Dermatol 33:347\u2013348","journal-title":"Clin Exp Dermatol"},{"key":"1767_CR10","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1016\/j.jaad.2005.10.037","volume":"54","author":"Bentley","year":"2006","unstructured":"Bentley DD, Graves JE, Smith DI, Heffernan MP (2006) Efalizumab-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol 54:S242\u2013S243","journal-title":"J Am Acad Dermatol"},{"key":"1767_CR11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2340\/00015555-0393","volume":"88","author":"Durox","year":"2008","unstructured":"Durox H, Sparsa A, Loustaud-Ratti V et al (2008) Efalizumab-induced lupus-like syndrome. Acta Derm Venereol 88:270\u2013271","journal-title":"Acta Derm Venereol"},{"key":"1767_CR12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(02)09798-2","volume":"360","author":"Ferraccioli","year":"2002","unstructured":"Ferraccioli GF, Assaloni R, Perin A (2002) Drug-induced systemic lupus erythematosus and TNF-alpha blockers. Lancet 360:645","journal-title":"Lancet"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-009-1767-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-009-1767-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-009-1767-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T03:30:13Z","timestamp":1684985413000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-009-1767-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,14]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["1767"],"URL":"https:\/\/doi.org\/10.1007\/s00105-009-1767-4","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,14]]}}}